Bicyclic-fused heteroaryl or aryl compounds as irak4 modulators

Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula IIc to IIi, IIl to IIv or IIx as defined in the claims. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermedia...

Full description

Saved in:
Bibliographic Details
Main Authors JOSEPH WALTER STROHBACH, STEPHEN WAYNE WRIGHT, ARTHUR LEE, KATHERINE LIN LEE, JOHN DAVID TRZUPEK, DAVID HEPWORTH, JOHN PAUL MATHIAS, NIKOLAOS PAPAIOANNOU, LORI KRIM GAVRIN, CHRISTOPH MARTIN DEHNHARDT, FRANK ELDRIDGE LOVERING, EDDINE SAIAH, CHRISTOPH WOLFGANG ZAPF, SEUNGIL HAN, Dafydd Rhys OWEN, Christophe Philippe ALLAIS
Format Patent
LanguageEnglish
Hebrew
Published 30.06.2021
Online AccessGet full text

Cover

More Information
Summary:Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula IIc to IIi, IIl to IIv or IIx as defined in the claims. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
Bibliography:Application Number: IL20210282771